Denmark’s Zealand Pharma A/S has expanded its capacity for developing peptide-based medicines with the acquisition of Encycle Therapeutics Inc, a private Canadian company with a preclinical asset for gastrointestinal diseases. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
